← Open Payments lookup

KELISIA MCKAY: Open Payments

NPI 1962447045 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$246 in 12 payments from 8 companies in 2025. Trend: 2023 $1,267 · 2024 $1,409 · 2025 $246

Food & beverage: $246
CompanyPaymentsAmount
Gilead Sciences, Inc.4$86
E.R. Squibb & Sons, L.L.C.1$43
ABBVIE INC.2$32
Neurocrine BioSciences, Inc.1$21
Lundbeck LLC1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Cipher Pharmaceuticals US LLC1$14
Axsome Therapeutics, Inc.1$14

Products named: COBENFY, VRAYLAR, INGREZZA, REXULTI, XIFAXAN, Natroba, Auvelity.

Industry payments across LA — which companies pay providers there.